[Antiblastic treatment in metastatic colorectal cancer].
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002945:Cisplatin / Q000008:administration & dosage; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D005468:Fluorodeoxyuridylate / Q000627:therapeutic use; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007261:Infusions, Intra-Arterial; D007372:Interferons / Q000627:therapeutic use; D016685:Mitomycin / Q000008:administration & dosage / Q000627:therapeutic use; D012673:Semustine / Q000008:administration & dosage / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D005468:Fluorodeoxyuridylate; D012673:Semustine; D016685:Mitomycin; D007372:Interferons; D002945:Cisplatin; D005472:Fluorouracil
Il trattamento antiblastico del cancro colorettale metastatico.